Cargando…

EGFR is required for Wnt9a/Fzd9b signalling specificity in haematopoietic stem cells

Wnt signalling drives a plethora of processes in development, homeostasis, and disease; however, the role and mechanism of individual ligand/receptor (Wnt/Frizzled, Fzd) interactions in specific biological processes remain poorly understood. Wnt9a is specifically required for the amplification of bl...

Descripción completa

Detalles Bibliográficos
Autores principales: Grainger, Stephanie, Nguyen, Nicole, Richter, Jenna, Setayesh, Jordan, Lonquich, Brianna, Oon, Chet Huan, Wozniak, Jacob M., Barahona, Rocio, Kamei, Caramai N., Houston, Jack, Carrillo-Terrazas, Marvic, Drummond, Iain A., Gonzalez, David, Willert, Karl, Traver, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559346/
https://www.ncbi.nlm.nih.gov/pubmed/31110287
http://dx.doi.org/10.1038/s41556-019-0330-5
Descripción
Sumario:Wnt signalling drives a plethora of processes in development, homeostasis, and disease; however, the role and mechanism of individual ligand/receptor (Wnt/Frizzled, Fzd) interactions in specific biological processes remain poorly understood. Wnt9a is specifically required for the amplification of blood progenitor cells during development. Using genetic studies in zebrafish and human embryonic stem cells, paired with in vitro cell biology and biochemistry, we have determined that Wnt9a signals specifically through Fzd9b to elicit β-catenin-dependent Wnt signalling that regulates haematopoietic stem and progenitor cell emergence. We demonstrate that the epidermal growth factor receptor (EGFR) is required as a co-factor for Wnt9a/Fzd9b signalling. EGFR-mediated phosphorylation of one tyrosine residue on the Fzd9b intracellular tail in response to Wnt9a promotes internalization of the Wnt9a/Fzd9b/LRP signalosome and subsequent signal transduction. These findings provide mechanistic insights for specific Wnt/Fzd signals, which will be crucial for specific therapeutic targeting and regenerative medicine.